CLINICAL TRIALS PROFILE FOR DURYSTA
✉ Email this page to a colleague
All Clinical Trials for durysta
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT07217678 ↗ | Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use | NOT_YET_RECRUITING | AbbVie | PHASE4 | 2026-01-31 | The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular surface inflammation, indicated by levels of caspase-1, an inflammatory biomarker. |
| NCT07217678 ↗ | Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use | NOT_YET_RECRUITING | University of Miami | PHASE4 | 2026-01-31 | The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular surface inflammation, indicated by levels of caspase-1, an inflammatory biomarker. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for durysta
Condition Name
Clinical Trial Locations for durysta
Trials by Country
Clinical Trial Progress for durysta
Clinical Trial Phase
Clinical Trial Sponsors for durysta
Sponsor Name
